Sharklet Technologies
About:
Sharklet Technologies, Inc. is a biotechnology company that develops and brings to market surface technologies.
Website: http://www.sharklet.com/
Top Investors: National Institute of Diabetes and Digestive and Kidney Diseases
Description:
Sharklet Technologies, Inc. is a biotechnology company that develops and brings to market surface technologies that manage microorganisms to make the world a healthier, environmentally safer and better place. The company’s patented, core technology, called Sharklet™, is the first no-kill, non-toxic and environmentally-friendly surface texture designed to inhibit bacterial growth including MRSA, E. coli, Staph a., Pseudomonas aeruginosa, VRE and a host of other bacteria. The Sharklet surface is comprised of millions of microscopic diamonds that are arranged into a distinct texture. It is this texture that bacteria find inhospitable for growth. Inspired by the natural microbe-resistant properties of sharkskin, Sharklet is a simple solution for a complex problem. Sharklet is a platform technology with broad applications from germ-prone surfaces in healthcare and childcare facilities to consumer goods and medical devices. The company has already licensed its technology for a urinary catheter that is currently in clinical trials with the aim to reduce catheter-associated urinary tract infections.
$3.67M
$1M to $10M
Aurora, Colorado, United States
2008-02-01
Info(AT)sharklet.com
Anthony Brennan, Jason Morton, Mark Spiecker
11-50
2014-12-26
Private
© 2025 bioDAO.ai